+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cas9 Nuclease Market - Global Forecast 2025-2030- Product Image
Cas9 Nuclease Market - Global Forecast 2025-2030- Product Image
Sale

Cas9 Nuclease Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6121684
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In the fast-changing field of genome editing, Cas9 nuclease stands as the core driver behind innovative research and therapeutic development worldwide. Cas9 technology is vital for organizations seeking to enhance genetic engineering precision, streamline R&D pipelines, and remain competitive in a landscape marked by rapid technological advancement and shifting regulatory requirements.

Market Snapshot: Cas9 Nuclease Market Trends and Outlook

The global Cas9 nuclease market has experienced significant growth, driven by rising demand across basic research, functional genomics, and clinical development sectors. With expanding applications in drug discovery, disease modeling, and personalized medicine, Cas9’s modularity positions it as a foundational tool for diverse genome editing initiatives. Market momentum is further supported by regional investments in biomanufacturing, public-private partnerships, and the introduction of innovative reagent formats and delivery systems. As international collaboration and competitive differentiation intensify, organizations are focusing on integrated solutions and adaptable supply chain strategies to maintain progress even amid global trade fluctuations and evolving standards.

Scope & Segmentation: Comprehensive Analysis Across Applications, Delivery, and Regions

This report provides a detailed review of the Cas9 nuclease landscape, supported by robust market segmentation and geographic coverage:

  • Formats: Kits and reagents (including custom, genome editing, and screening kits), plasmid vectors, purified proteins, and ribonucleoprotein complexes.
  • Applications: Base editing (adenine/cytosine), epigenome editing (DNA methylation, histone modification), gene activation, knockin, knockout, gene repression, and multiplexed editing strategies.
  • End Users: Academic and research institutes, biotechnology firms, large pharmaceutical companies, and contract research organizations focused on clinical and preclinical services.
  • Delivery Methods: Non-viral approaches such as electroporation, lipid nanoparticles, microinjection, and nanoparticle conjugates, alongside viral vectors (AAV, adenoviral, lentiviral).
  • Therapeutic Areas: Genetic disorders, infectious diseases, oncology, and emerging areas in functional genomics.
  • Cas9 Types: Wild-type, dead Cas9 (for CRISPR activation/interference), high-fidelity variants (e.g., ESpCas9, SpCas9 HF1), and nickases (D10A, H840A).
  • Regions: Americas (key US states, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (including UK, Germany, France, Russia, and select Middle Eastern and African countries), and Asia-Pacific (with leading contributions from China, Japan, South Korea, India, and Australia).
  • Leading Companies: Review covers Thermo Fisher Scientific, Merck KGaA, New England Biolabs, Integrated DNA Technologies, GenScript Biotech, Agilent Technologies, Promega, Synthego, Addgene, and Takara Bio.

Key Takeaways for Senior Decision-Makers

  • Continual Cas9 enzyme innovation, such as high-fidelity and dead Cas9 variants, is expanding the range of research and clinical genome editing capabilities and reducing off-target effects.
  • Diverse delivery technologies, from non-viral formulations to viral vectors, enable customization for applications as varied as ex vivo cell therapy and in vivo gene correction.
  • Regulatory harmonization across major markets is enabling earlier clinical translation and greater confidence in risk management, while ethical oversight directs research focus and commercialization potential.
  • Strategic partnerships between large biopharma, CROs, academia, and reagent suppliers are driving scalability, resource efficiency, and validated performance across multiple therapeutic areas.
  • Emerging regions, particularly in the Asia-Pacific, are playing an increasingly active role in bioprocessing and novel technology development, influencing global supply chains and innovation networks.
  • Competitive dynamics continue to evolve, with mergers and acquisitions reshaping market leadership and accelerating integrated platform development.

Tariff Impact on Cas9 Nuclease Ecosystem

The United States’ targeted import tariffs on Cas9 reagents and delivery materials, commencing in 2025, have introduced new procurement and logistical challenges. Stakeholders are mitigating cost pressures by investing in near-shoring, diversifying supplier bases, and establishing regional manufacturing capabilities. These adaptations, while fostering local resilience, require careful balance between operational cost containment and the pursuit of state-of-the-art research outcomes.

Research Methodology & Data Sources

Insights in this report are derived from a combination of structured interviews with key stakeholders (researchers, industry leaders, regulators), analysis of peer-reviewed journals, regulatory filings, patents, and company disclosures. Scenario-based evaluation and expert workshops further validate the strategic and operational implications highlighted throughout the report.

Why This Report Matters

  • Provides clarity on global Cas9 nuclease market dynamics and competitive positioning to support informed investment and M&A decisions.
  • Equips R&D and operations leaders with segmentation detail, regulatory context, and best-practice strategies to accelerate innovation and minimize risk.

Conclusion

Cas9 nuclease remains central to genome editing advances, offering both flexibility and precision to support diverse research and clinical goals. Strategic adoption of emerging variants, delivery platforms, and supply models will be key for organizations seeking long-term relevance and leadership in this evolving market.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid advances in delivery technologies to improve Cas9 specificity and reduce off-target effects
5.2. Emergence of base editing and prime editing modalities to expand Cas9 nuclease applications
5.3. Growing partnerships between biotech companies and academic institutions to accelerate Cas9 clinical pipelines
5.4. Regulatory frameworks evolving for in vivo gene editing therapies using Cas9 nucleases
5.5. Increasing adoption of high-fidelity Cas9 variants to enhance therapeutic safety profiles
5.6. Rising investment in CRISPR agnostic screening platforms to identify novel Cas9 target sites
5.7. Development of CRISPR-Cas9 derived diagnostics for rapid point-of-care genetic disease detection
5.8. Expansion of agricultural gene editing applications using Cas9 nucleases for crop trait enhancement
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cas9 Nuclease Market, by Format
8.1. Introduction
8.2. Kits & Reagents
8.2.1. Custom Kits
8.2.2. Genome Editing Kits
8.2.3. Screening Kits
8.3. Plasmid Vectors
8.4. Purified Proteins
8.5. Ribonucleoprotein Complexes
9. Cas9 Nuclease Market, by Application
9.1. Introduction
9.2. Base Editing
9.2.1. Adenine Base Editing
9.2.2. Cytosine Base Editing
9.3. Epigenome Editing
9.3.1. DNA Methylation
9.3.2. Histone Modification
9.4. Gene Activation
9.5. Gene Knockin
9.6. Gene Knockout
9.7. Gene Repression
10. Cas9 Nuclease Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Biotechnology & Pharmaceutical Companies
10.3.1. Biotechnology Firms
10.3.2. Large Pharma Companies
10.4. Contract Research Organizations
10.4.1. Clinical Services
10.4.2. Preclinical Services
11. Cas9 Nuclease Market, by Delivery Method
11.1. Introduction
11.2. Non-Viral Methods
11.2.1. Electroporation
11.2.2. Lipid Nanoparticles
11.2.3. Microinjection
11.2.4. Nanoparticle Conjugates
11.3. Viral Vectors
11.3.1. AAV
11.3.2. Adenoviral
11.3.3. Lentiviral
12. Cas9 Nuclease Market, by Therapeutic Area
12.1. Introduction
12.2. Genetic Disorders
12.3. Infectious Diseases
12.4. Oncology
13. Cas9 Nuclease Market, by Type
13.1. Introduction
13.2. Dead Cas9
13.2.1. CRISPR Activation
13.2.2. CRISPR Interference
13.3. High-Fidelity Variants
13.3.1. ESpCas9
13.3.2. SpCas9 HF1
13.4. Nickase
13.4.1. D10A
13.4.2. H840A
13.5. Wild-Type
14. Americas Cas9 Nuclease Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cas9 Nuclease Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cas9 Nuclease Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Merck KGaA
17.3.3. New England Biolabs, Inc.
17.3.4. Integrated DNA Technologies, Inc.
17.3.5. GenScript Biotech Corporation
17.3.6. Agilent Technologies, Inc.
17.3.7. Promega Corporation
17.3.8. Synthego Corporation
17.3.9. Addgene, Inc.
17.3.10. Takara Bio Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CAS9 NUCLEASE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CAS9 NUCLEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CAS9 NUCLEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CAS9 NUCLEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CAS9 NUCLEASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CAS9 NUCLEASE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CAS9 NUCLEASE MARKET: RESEARCHAI
FIGURE 28. CAS9 NUCLEASE MARKET: RESEARCHSTATISTICS
FIGURE 29. CAS9 NUCLEASE MARKET: RESEARCHCONTACTS
FIGURE 30. CAS9 NUCLEASE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CAS9 NUCLEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CAS9 NUCLEASE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CAS9 NUCLEASE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY CUSTOM KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY CUSTOM KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY GENOME EDITING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY GENOME EDITING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY SCREENING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY SCREENING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY PLASMID VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY PLASMID VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY PURIFIED PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY PURIFIED PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY RIBONUCLEOPROTEIN COMPLEXES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY RIBONUCLEOPROTEIN COMPLEXES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY ADENINE BASE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY ADENINE BASE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY CYTOSINE BASE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY CYTOSINE BASE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY DNA METHYLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY HISTONE MODIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY HISTONE MODIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY GENE ACTIVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY GENE ACTIVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY GENE KNOCKIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY GENE KNOCKIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY GENE KNOCKOUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY GENE KNOCKOUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY GENE REPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY GENE REPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY LARGE PHARMA COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY LARGE PHARMA COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY ELECTROPORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY MICROINJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY NANOPARTICLE CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY NANOPARTICLE CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY AAV, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY AAV, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY ADENOVIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY ADENOVIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY LENTIVIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY LENTIVIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY CRISPR ACTIVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY CRISPR ACTIVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY CRISPR INTERFERENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY CRISPR INTERFERENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY ESPCAS9, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY ESPCAS9, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY SPCAS9 HF1, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY SPCAS9 HF1, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY NICKASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY NICKASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY D10A, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY D10A, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY H840A, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY H840A, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY NICKASE, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY NICKASE, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY WILD-TYPE, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL CAS9 NUCLEASE MARKET SIZE, BY WILD-TYPE, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY NICKASE, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY NICKASE, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS CAS9 NUCLEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY NICKASE, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY NICKASE, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES CAS9 NUCLEASE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 201. CANADA CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
TABLE 202. CANADA CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
TABLE 203. CANADA CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 204. CANADA CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 205. CANADA CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. CANADA CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. CANADA CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 208. CANADA CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 209. CANADA CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2018-2024 (USD MILLION)
TABLE 210. CANADA CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2025-2030 (USD MILLION)
TABLE 211. CANADA CAS9 NUCLEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. CANADA CAS9 NUCLEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. CANADA CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 214. CANADA CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 215. CANADA CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 216. CANADA CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 217. CANADA CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 218. CANADA CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 219. CANADA CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 220. CANADA CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 221. CANADA CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, 2018-2024 (USD MILLION)
TABLE 222. CANADA CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, 2025-2030 (USD MILLION)
TABLE 223. CANADA CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 224. CANADA CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 225. CANADA CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 226. CANADA CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 227. CANADA CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, 2018-2024 (USD MILLION)
TABLE 228. CANADA CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, 2025-2030 (USD MILLION)
TABLE 229. CANADA CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, 2018-2024 (USD MILLION)
TABLE 230. CANADA CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, 2025-2030 (USD MILLION)
TABLE 231. CANADA CAS9 NUCLEASE MARKET SIZE, BY NICKASE, 2018-2024 (USD MILLION)
TABLE 232. CANADA CAS9 NUCLEASE MARKET SIZE, BY NICKASE, 2025-2030 (USD MILLION)
TABLE 233. MEXICO CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
TABLE 234. MEXICO CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
TABLE 235. MEXICO CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 237. MEXICO CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. MEXICO CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. MEXICO CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 240. MEXICO CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 241. MEXICO CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2018-2024 (USD MILLION)
TABLE 242. MEXICO CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2025-2030 (USD MILLION)
TABLE 243. MEXICO CAS9 NUCLEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. MEXICO CAS9 NUCLEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. MEXICO CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 246. MEXICO CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 247. MEXICO CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 248. MEXICO CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 249. MEXICO CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 250. MEXICO CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 251. MEXICO CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 252. MEXICO CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 253. MEXICO CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, 2018-2024 (USD MILLION)
TABLE 254. MEXICO CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, 2025-2030 (USD MILLION)
TABLE 255. MEXICO CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 256. MEXICO CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 257. MEXICO CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 258. MEXICO CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 259. MEXICO CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, 2018-2024 (USD MILLION)
TABLE 260. MEXICO CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, 2025-2030 (USD MILLION)
TABLE 261. MEXICO CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, 2018-2024 (USD MILLION)
TABLE 262. MEXICO CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, 2025-2030 (USD MILLION)
TABLE 263. MEXICO CAS9 NUCLEASE MARKET SIZE, BY NICKASE, 2018-2024 (USD MILLION)
TABLE 264. MEXICO CAS9 NUCLEASE MARKET SIZE, BY NICKASE, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY NICKASE, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL CAS9 NUCLEASE MARKET SIZE, BY NICKASE, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY VIRAL VECTORS, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 323. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, 2018-2024 (USD MILLION)
TABLE 324. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY DEAD CAS9, 2025-2030 (USD MILLION)
TABLE 325. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, 2018-2024 (USD MILLION)
TABLE 326. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY HIGH-FIDELITY VARIANTS, 2025-2030 (USD MILLION)
TABLE 327. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY NICKASE, 2018-2024 (USD MILLION)
TABLE 328. ARGENTINA CAS9 NUCLEASE MARKET SIZE, BY NICKASE, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2018-2024 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY EPIGENOME EDITING, 2025-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 347. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 348. EUROPE, MIDDLE EAST & AFRICA CAS9 NUCLEASE MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 349. EUROPE, MIDDLE EAST & AFRICA CAS9 NUC

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cas9 Nuclease market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • Integrated DNA Technologies, Inc.
  • GenScript Biotech Corporation
  • Agilent Technologies, Inc.
  • Promega Corporation
  • Synthego Corporation
  • Addgene, Inc.
  • Takara Bio Inc.

Related Topics

Related Reports

Cas Nuclease Market Report 2025 - Product Image

Cas Nuclease Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cas12 Nuclease Market - Global Forecast 2025-2030 - Product Image

Cas12 Nuclease Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Zinc Finger Nuclease Technology Market - Global Forecast 2025-2030 - Product Image

Zinc Finger Nuclease Technology Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Industrial Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases, and Nucleases), Application (Food & Beverages, Bioethanol, Feed, Detergents, Wastewater, Soil, and Oil Treatment), Source, Formulation, and Region - Global Forecast to 2030 - Product Image

Industrial Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases, and Nucleases), Application (Food & Beverages, Bioethanol, Feed, Detergents, Wastewater, Soil, and Oil Treatment), Source, Formulation, and Region - Global Forecast to 2030

  • Report
  • 366 Pages
  • Global
From
Protein Engineering: Market Share, and Growth Analysis by Product Type (Recombinant Proteins, Monoclonal Antibodies, Enzymes), Application, End User, Technology - Product Image

Protein Engineering: Market Share, and Growth Analysis by Product Type (Recombinant Proteins, Monoclonal Antibodies, Enzymes), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.